Lionheart

"This seed funding and support from major investors who have serious experience in supporting companies to scale, our partnerships with companies in Europe and North America, and getting the green light for the first trial at our London facility, shows that Clerkenwell Health is well and truly open for business. Momentum for psychedelics-assisted therapy is building, and we’re excited to be at the forefront of that charge."

"Psychedelic assisted therapy could be ground-breaking for mental health treatment, and the UK is well-placed to be at the vanguard of that as a global leader in clinical trials post-Brexit. Clerkenwell Health’s aim is to establish the UK as the heart of the commercial psychedelic research ecosystem, working closely with mental health experts and drug developers around the world to tackle some of the most complex mental health conditions."

"Music has a profound impact on therapeutic outcomes, but many therapists are in the dark on how to best work with music in their practice,"